Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
Luis Brandão(University of Colorado Anschutz Medical Campus), Douglas K. Graham(Emory University)
Cited by 57
Related Papers
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
|Oncogene|2013|105
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
|JCI Insight|2016|78